Regentis Biomaterials Ltd RGNT

$1.85 -0.04 (-2.12%)

Valuation

Market cap
9,789,000
Revenue TTM
$0
Net income TTM
$-13,650,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
58,700
Avg volume
62,490
Day's range
$1.80 – $1.92
Shares out
5,179,000
Stochastic %K
16%
Beta
—
Analysts
Strong Sell
Price target
$10.00

Price

Company profile

Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment...

Show more

Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel.

Industry
Medical Instruments & Supplies
Sector
Healthcare
Phone
972 9 960 1917
Website
https://www.regentis.co.il
Address
60, Medinat Hayehudim, Entrance C Herzlia Pituach, Herzliya, Israel

Latest news

Stocktwits

NetworkNewsWire Sep 28, 6:49 PM
Regentis Biomaterials and the Shift from Symptom Management to Structural Repair in Knee Cartilage Care $RGNT https://ibn.fm/xe3zA
0 replies
MadStockAlerts1 Sep 25, 3:00 AM
$RGNT $FTFT what a beautiful same day move. Dozens of them. Check my profile. You know how we find them? We use AI scanners and proprietary software to find the best set ups and we alert the shit our it to our members who bank. Bangers. ‼️ See yourself here: http://www.madstockalerts.com
0 replies
NVDAMillionaire Sep 22, 11:07 AM
$RGNT Really good write-up that perfectly summarizes RGNT's present situation. So if you want to bring your RGNT knowledge up to date or just discover RGNT, this is required reading. https://everyticker.com/quote/RGNT/analysis/manufacturing-breakthrough-meets-clinical-inflection-at-regentis-biomaterials-nyse-american-rgnt
0 replies
foxfur Sep 21, 6:56 PM
$RGNT does anybody know why we are on fire!?
0 replies
sneeds_feed_N_seed Sep 21, 2:53 PM
$RGNT Still cheap.
0 replies
wdcstocks Sep 21, 2:25 PM
$RGNT UP 25%
0 replies
TA_Kongen Sep 21, 2:18 PM
$RGNT Walking up. To private placement buyer level at 3.50?
0 replies
Losseditall Sep 21, 2:15 PM
$RGNT wasn’t there supposed to be doc training in Europe?
0 replies